Edwards Cash and Equivalents vs Investments Analysis

EW Stock  USD 95.15  1.73  1.85%   
Edwards Lifesciences financial indicator trend analysis is much more than just examining Edwards Lifesciences Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edwards Lifesciences Corp is a good investment. Please check the relationship between Edwards Lifesciences Cash And Equivalents and its Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

Cash And Equivalents vs Investments

Cash and Equivalents vs Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edwards Lifesciences Corp Cash and Equivalents account and Investments. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Edwards Lifesciences' Cash and Equivalents and Investments is -0.06. Overlapping area represents the amount of variation of Cash and Equivalents that can explain the historical movement of Investments in the same time period over historical financial statements of Edwards Lifesciences Corp, assuming nothing else is changed. The correlation between historical values of Edwards Lifesciences' Cash and Equivalents and Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash and Equivalents of Edwards Lifesciences Corp are associated (or correlated) with its Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Investments has no effect on the direction of Cash and Equivalents i.e., Edwards Lifesciences' Cash and Equivalents and Investments go up and down completely randomly.

Correlation Coefficient

-0.06
Relationship DirectionNegative 
Relationship StrengthInsignificant

Cash And Equivalents

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.
Most indicators from Edwards Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
Selling General Administrative is likely to climb to about 1.8 B in 2024, whereas Tax Provision is likely to drop slightly above 201.8 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit4.0B4.3B4.6B4.9B
Total Revenue5.2B5.4B6.0B6.3B

Edwards Lifesciences fundamental ratios Correlations

-0.450.880.990.970.920.990.80.810.970.7-0.910.720.960.98-0.630.760.940.960.480.93-0.680.730.850.810.4
-0.45-0.43-0.48-0.48-0.37-0.46-0.4-0.31-0.41-0.340.32-0.13-0.45-0.450.14-0.23-0.5-0.41-0.14-0.410.31-0.51-0.36-0.420.18
0.88-0.430.820.80.690.870.650.740.850.74-0.80.680.850.82-0.340.810.770.850.610.91-0.470.610.770.640.25
0.99-0.480.820.990.950.980.840.750.970.66-0.90.630.970.97-0.690.670.970.940.370.87-0.680.750.790.810.34
0.97-0.480.80.990.930.980.80.710.970.67-0.860.640.960.97-0.660.670.960.910.320.87-0.70.780.770.840.31
0.92-0.370.690.950.930.890.930.730.930.45-0.870.520.930.91-0.870.530.960.910.270.73-0.660.580.730.790.35
0.99-0.460.870.980.980.890.770.720.950.76-0.870.70.940.95-0.580.750.920.90.460.92-0.610.80.790.790.36
0.8-0.40.650.840.80.930.770.610.830.33-0.80.290.880.74-0.860.350.910.810.190.58-0.540.440.620.740.16
0.81-0.310.740.750.710.730.720.610.760.42-0.830.780.720.84-0.550.750.680.920.630.8-0.690.320.930.630.61
0.97-0.410.850.970.970.930.950.830.760.61-0.880.630.980.95-0.670.680.960.950.320.87-0.750.670.820.790.28
0.7-0.340.740.660.670.450.760.330.420.61-0.520.720.630.63-0.040.810.550.560.60.79-0.350.880.590.530.37
-0.910.32-0.8-0.9-0.86-0.87-0.87-0.8-0.83-0.88-0.52-0.59-0.9-0.890.62-0.59-0.88-0.93-0.48-0.830.62-0.52-0.85-0.75-0.46
0.72-0.130.680.630.640.520.70.290.780.630.72-0.590.570.73-0.270.960.480.720.760.85-0.560.540.820.590.74
0.96-0.450.850.970.960.930.940.880.720.980.63-0.90.570.93-0.680.630.980.930.330.85-0.690.690.790.840.26
0.98-0.450.820.970.970.910.950.740.840.950.63-0.890.730.93-0.640.740.920.960.410.91-0.750.690.860.810.41
-0.630.14-0.34-0.69-0.66-0.87-0.58-0.86-0.55-0.67-0.040.62-0.27-0.68-0.64-0.22-0.74-0.67-0.05-0.370.51-0.23-0.48-0.64-0.3
0.76-0.230.810.670.670.530.750.350.750.680.81-0.590.960.630.74-0.220.530.740.780.88-0.50.610.790.580.6
0.94-0.50.770.970.960.960.920.910.680.960.55-0.880.480.980.92-0.740.530.910.230.78-0.690.680.740.820.22
0.96-0.410.850.940.910.910.90.810.920.950.56-0.930.720.930.96-0.670.740.910.480.89-0.760.550.920.790.44
0.48-0.140.610.370.320.270.460.190.630.320.6-0.480.760.330.41-0.050.780.230.480.61-0.060.310.610.320.74
0.93-0.410.910.870.870.730.920.580.80.870.79-0.830.850.850.91-0.370.880.780.890.61-0.670.710.890.80.44
-0.680.31-0.47-0.68-0.7-0.66-0.61-0.54-0.69-0.75-0.350.62-0.56-0.69-0.750.51-0.5-0.69-0.76-0.06-0.67-0.44-0.8-0.68-0.26
0.73-0.510.610.750.780.580.80.440.320.670.88-0.520.540.690.69-0.230.610.680.550.310.71-0.440.510.620.21
0.85-0.360.770.790.770.730.790.620.930.820.59-0.850.820.790.86-0.480.790.740.920.610.89-0.80.510.750.6
0.81-0.420.640.810.840.790.790.740.630.790.53-0.750.590.840.81-0.640.580.820.790.320.8-0.680.620.750.31
0.40.180.250.340.310.350.360.160.610.280.37-0.460.740.260.41-0.30.60.220.440.740.44-0.260.210.60.31
Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.5B7.2B8.5B8.3B9.4B9.8B
Other Current Liab6.4M39.3M3.9M311M15.2M14.4M
Total Current Liabilities902.4M893.9M1.0B1.0B1.2B1.3B
Total Stockholder Equity4.1B4.6B5.8B5.8B6.7B7.0B
Property Plant And Equipment Net1.1B1.5B1.6B1.7B1.8B1.9B
Retained Earnings3.7B4.6B6.1B7.6B9.0B9.4B
Non Current Assets Total3.5B4.1B5.3B5.2B5.3B5.6B
Non Currrent Assets Other101.8M119.6M110.8M299.1M463.7M486.9M
Cash And Short Term Investments1.5B1.4B1.5B1.2B1.6B1.7B
Net Receivables599.1M602.8M664.9M699.1M836.9M878.7M
Good Will1.2B1.2B1.2B1.2B1.3B688.6M
Common Stock Shares Outstanding636.7M631.9M631.2M624.2M609.4M550.8M
Liabilities And Stockholders Equity6.5B7.2B8.5B8.3B9.4B9.8B
Non Current Liabilities Total1.4B1.8B1.6B1.5B1.4B800.7M
Inventory640.9M802.3M726.7M875.5M1.2B1.2B
Other Current Assets168M208.2M237.1M195.9M239.3M251.3M
Other Stockholder Equity344.6M(466M)(716.5M)(2.2B)(2.8B)(2.6B)
Total Liab2.3B2.7B2.7B2.5B2.6B1.4B
Property Plant And Equipment Gross1.1B1.5B1.6B1.7B2.7B2.8B
Total Current Assets3.0B3.1B3.2B3.1B4.0B4.2B
Accumulated Other Comprehensive Income(156M)(161.1M)(157.7M)(254.9M)(242.8M)(230.7M)
Short Long Term Debt Total593.8M678.8M694.9M690.3M691.3M486.4M
Other Liab784.1M1.1B969.6M797.6M917.2M963.1M
Net Debt(500.3M)(488.3M)(172.5M)(77.7M)(449.1M)(426.6M)
Accounts Payable180.4M196.5M204.5M201.9M201.4M139.5M
Cash1.2B1.2B862.8M769M1.1B1.2B
Other Assets274M1.2B357.5M783.1M900.6M945.6M
Long Term Debt594.4M595M595.7M596.3M597M425.6M
Common Stock Total Equity218.1M636.4M642M646.3M743.2M780.4M
Short Term Debt598M0.025.5M27.2M24.9M23.7M
Intangible Assets336.5M331.4M323.6M285.2M428.4M449.8M
Common Stock218.1M636.4M642M646.3M650.5M683.0M
Property Plant Equipment1.1B1.4B1.6B1.7B2.0B2.1B
Treasury Stock(1.0B)(1.3B)(1.9B)(2.4B)(2.2B)(2.1B)
Short Term Investments337.8M219.4M604M446.3M500.5M382.6M
Net Tangible Assets2.9B3.4B4.3B4.4B5.0B5.3B
Retained Earnings Total Equity3.7B4.6B6.1B7.6B8.7B9.2B
Capital Surpluse1.6B1.4B1.7B2.0B2.3B1.2B
Long Term Investments585.5M801.6M1.8B1.2B583.9M582.2M

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Edwards Stock

  0.86SSY SunLink Health SystemsPairCorr
  0.69TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.65DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.65FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.62NEOG Neogen Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.3
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.